Emcure Pharmaceuticals IPO allotment date and time: The initial public offering (IPO) of Emcure Pharmaceuticals received heavy bids from investors.
The basis of the allotment of Emcure Pharmaceuticals shares is scheduled for Monday, July 8, 2024.
Emcure Pharmaceuticals IPO Shares Listing DateThe shares of Emcure Pharmaceuticals are likely to make their debut on the bourses on Wednesday, July 10, 2024.
Emcure Pharmaceuticals IPO Final Subscription StatusThe IPO was subscribed 67.87 times by the public till the last day of subscription.
Emcure Pharmaceuticals IPO Latest GMP PriceShares of Emcure Pharmaceuticals are commanding a strong premium ahead of their listing.
Authored by : Kumar Gaurav Updated Jul 5, 2024 | 07:39 PM IST Photo : ET Now Digital Investors can check the share allotment status on the BSE website or the official website of the IPO’s registrar.
Emcure Pharmaceuticals IPO allotment date and time: The initial public offering (IPO) of Emcure Pharmaceuticals received heavy bids from investors. The three-day subscription window for the IPO opened on Wednesday, July 3, 2024, and closed today, Friday, July 5, 2024.
After bidding for the IPO, the next step is the allotment of shares. The basis of the allotment of Emcure Pharmaceuticals shares is scheduled for Monday, July 8, 2024. Investors can check the share allotment status on the BSE website or the official website of the IPO’s registrar.
Emcure Pharmaceuticals IPO Shares Listing Date
The shares of Emcure Pharmaceuticals are likely to make their debut on the bourses on Wednesday, July 10, 2024.
Emcure Pharmaceuticals IPO Final Subscription Status
The IPO was subscribed 67.87 times by the public till the last day of subscription. Emcure Pharmaceuticals IPO was subscribed 191.24 times in the QIB category, 49.32 times in the NII category, and 7.36 times in the retail category.
Emcure Pharmaceuticals IPO Latest GMP Price
Shares of Emcure Pharmaceuticals are commanding a strong premium ahead of their listing. The grey market premium (GMP) for an IPO indicates the difference between the unofficial market price of a company's shares before they are officially listed and the IPO price.
According to several websites tracking grey market activities, shares of Emcure Pharmaceuticals are commanding a premium of 36.21 per cent. This translates into a grey market premium of Rs 365 at the upper end of the IPO price.
Emcure Pharmaceuticals IPO Details
The public issue of Emcure Pharmaceuticals comprises a fresh issue of 7,936,507 equity shares aggregating up to Rs 800 crore and an offer for sale by promoters of 11,428,839 shares aggregating up to Rs 1,152.03 crore. The company had fixed the lot size at 14 shares. The price band for Emcure Pharmaceuticals is Rs 960 - Rs 1008 per share. Investors could bid for a minimum of 14 shares and in multiples thereof, with the minimum amount required by a retail investor at Rs 14,112.
Emcure Pharmaceuticals intends to use the net proceeds from the public offering for the repayment and/or prepayment of all or a portion of certain outstanding borrowings. The remaining amount will be used for general corporate purposes.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
